A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
UTC Therapeutics Inc.
Suzhou Genhouse Bio Co., Ltd.
Beijing Friendship Hospital
Peking University Third Hospital
NGM Biopharmaceuticals, Inc
Wellmarker Bio
Universitair Ziekenhuis Brussel
Kineta Inc.
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Chongqing Precision Biotech Co., Ltd
Wuhan Ammunition Life-tech Co., Ltd
Provectus Pharmaceuticals
Blue Note Therapeutics
Wellmarker Bio
Betta Pharmaceuticals Co., Ltd.
Assistance Publique - Hôpitaux de Paris
Weprom
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Kyunghee University Medical Center
SpeciCare
MetiMedi Pharmaceuticals
Royal Marsden NHS Foundation Trust
Shenzhen BinDeBio Ltd.
University of Magdeburg
Instituto do Cancer do Estado de São Paulo
Critical Outcome Technologies Inc.
Xuanwu Hospital, Beijing
The Netherlands Cancer Institute
NHS Greater Glasgow and Clyde
Southwest Hospital, China
SPGO Research Mannheim GmbH
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Chinese PLA General Hospital
The Leeds Teaching Hospitals NHS Trust
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hadassah Medical Organization
Poniard Pharmaceuticals